The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 0 study to assess [111In]-DOTA-h11B6 to target human kallikrein-2 (hk2) in men with metastatic castration-resistant prostate cancer.
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; ORIC Pharmaceuticals; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Joseph A. O' Donoghue
Consulting or Advisory Role - Invicro; Janssen Research & Development
 
Dushen Chetty
Employment - Johnson & Johnson
 
Mike Russell
Employment - Johnson & Johnson
 
Emma Zulch
No Relationships to Disclose
 
Anjali Narayan Avadhani
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Chaitanya R. Divgi
Employment - Invicro; Johnson & Johnson
 
Neeta Pandit-Taskar
No Relationships to Disclose